Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands

Nature

Volumn 403, Issue 6770, 2000, Pages 669-672

  Kitov, Pavel I ^a   Sadowska, Joanna M ^a   Mulvey, George ^a   Armstrong, Glen D ^a   Ling, Hong ^a   Pannu, Navraj S ^b   Read, Randy J ^a,b   Bundle, David R ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN;

ARTICLE; BINDING AFFINITY; CELL SURFACE; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CARBOHYDRATE SEQUENCE; CARBOHYDRATES; CERCOPITHECUS AETHIOPS; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; GLYCOLIPIDS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OLIGOSACCHARIDES; PROTEIN CONFORMATION; RECEPTORS, CELL SURFACE; SHIGA-LIKE TOXIN I; VERO CELLS;

ASTEROIDEA; BACTERIA (MICROORGANISMS); ESCHERICHIA; MAMMALIA;

EID: 0034628502     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35001095     Document Type: Article

References (30)

1. Holmgren, J. & Svennerholm, A. M. Bacterial enteric infections and vaccine development. Gastroenterology Clinics of North America 21, 283-302 (1992).
2. 5 toxins. Curr. Opin. Struct. Biol. 5, 165-171 (1995).
3. Lindberg, A. A. et al. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae Type 1. J. Biol. Chem. 262, 1779-1785 (1987).
4. Aronson, M. et al. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl α-D-mannopyranoside. J. Infect. Dis. 139, 329-332 (1979).
5. Mammen, M., Choi, S.-K. & Whitesides, G. M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed. 37, 2754 (1998).
6. 3. Biochemistry 37, 1777-1788 (1998).
7. Karmali, M. A., Steele, B. T., Petric, M. & Lim, C. Sporadic cases of haemolytic-uremic syndrome associated with fecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1, 619-620 (1983).
8. Karmali, M. A. et al. The association between idiopathic hemolytic uremic syndrome and infection by Verotoxin-producing Escherichia coli. J. Infect. Dis. 151, 775-782 (1985).
9. Cimolai, N., Carter, J. E., Morrison, B. J. & Anderson, J. D. Risk factors for the progression of Escherichia coli O 157:H7 enteritis to hemolytic-uremic syndrome. J. Pediatr. 116, 589-592 (1990).
10. Boyd, B. & Lingwood, C. Verotoxin receptor glycolipid in human renal tissue. Nephron 51, 207-210 (1989).
11. Armstrong, G. D., Fodor, E. & Vanmaele, R. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences. J. Infect. Dis. 164, 1160-1167 (1991).
12. O'Brien, A. D. et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180, 65-94 (1992).
13. DeGrandis, S. et al. Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B. J. Bacteriol. 169, 4313-4319 (1987).
14. Stein, P. E., Boodhoo, A., Tyrrell, G. J., Brunton, J. L. & Read, R. J. Crystal structure of the cell-binding B oligomer of Verotoxin-1 from E. coli. Nature 355, 748-750 (1992).
15. St. Hilaire, P. M., Boyd, M. K. & Toone, E. J. Interaction of the Shiga-like type 1 B-subunit with its carbohydrate receptor. Biochemistry 33, 14452-14463 (1994).
16. Nyholm, P. G. et al. Two distinct binding sites for globotriaosyl on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem. Biol. 3, 263-275 (1996).
17. Bast, D. J., Banerjee, L., Clark, C., Read, R. J. & Brunton, J. L. The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit. Mol. Microbiol. 32, 953-960 (1999).
18. Shimizu, H., Field, R. A., Homans, S. W. & Donohue-Rolfe, A. Solution structure of the complex between the B-subunit homopentamer of Verotoxin VT-1 from Escherichia coli and the trisaccharide moiety of globotriaosylceramide. Biochemistry 31, 11078-11082 (1998).
19. Fuchs, G. et al. Pathogenesis of Shigella diarrhea: rabbit intestinal cell microvillus membrane binding site for Shigella toxin. Infect. Immun. 53, 372-377 (1986).
20. Dubber, M. & Lindhorst, T. K. Synthesis of octopus glycosides: core molecules for the construction of glyeoclusters and carbohydrate-centered dendrimers. Carbohydr. Res. 310, 35-41 (1998).
21. Kitov, P. I., Railton, C. & Bundle, D. R. The synthesis of 16-mercaptohexadecanyl glycosides for biosensor applications. Carbohydr. Res. 307, 361-369 (1998).
22. Tesh, V. L. et al. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect. Immun. 61, 3392-3402 (1993).
23. Mulvey, G., Vanmaele, R., Mrazek, M., Cahill, M. & Armstrong, G. D. Affinity purification of Shiga-like toxin I and Shiga-like toxin II. J. Microbiol. Methods 32, 247-252 (1998).
24. Navaza, J. AMoRe: an automated package for molecular replacement. Acta Crystallogr. A 50, 157-163 (1994).
25. Brünger, A. T. et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905-921 (1998).
26. Pannu, N. S. & Read, R. J. Improved structure refinement through maximum likelihood. Acta Crystallogr. A 52, 659-668 (1996).
27. McRee, D. E. XtalView/Xfit - a versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125, 156-165 (1999).
28. Read, R. J. Model phases: probabilities and bias. Methods Enzymol. 277, 110-128 (1997).
29. Kraulis, P. J. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).
30. Merritt, E. A. & Bacon, D. J. Raster3D: photorealistic molecular graphics. Methods Enzymol. 277, 505-524 (1997).